Business BIO-Europe, Barcelona, Spain, March 12, 2013

1. LEADINGREGENERATIVEMEDICINE 2. This presentation is intended to present a summary of ACT’s (“ACT”, or “Advanced CellTechnology Inc”, or “the Company”) salient…

Health & Medicine BIO CEO & Investor Conference, New York City, February 11, 2013

1. February 2013LEADINGREGENERATIVEMEDICINE 2. This presentation is intended to present a summary of ACT’s (“ACT”, or “Advanced CellTechnology Inc”, or “the Company”)…

Documents Treatment of Keratoconus Using Riboflavin-Induced Corneal Collagen Crosslinking

Authors: Anne Keating, M.D.1,2, Kathryn Colby, M.D., Ph.D.2, Roberto Pineda, M.D.2, Michael Endl, M.D.4, Thomas Elmer, M.D.4, Sandra Everett, M.D.1 and James Reidy, M.D.1…

Documents Authors: Anne Keating, M.D. 1,2, Kathryn Colby, M.D., Ph.D. 2, Roberto Pineda, M.D. 2, Michael Endl,...

Authors: Anne Keating, M.D.1,2, Kathryn Colby, M.D., Ph.D.2, Roberto Pineda, M.D.2, Michael Endl, M.D.4, Thomas Elmer, M.D.4, Sandra Everett, M.D.1 and James Reidy, M.D.1…